ArticleNeuroImage. Clinical2026
Subcortical microglial inflammation is uniquely linked to subpial cortical demyelination in multiple sclerosis.
Article in NeuroImage. Clinical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn multiple sclerosis (MS), pathology of both the subpial cortex and subependymal parenchyma has been strongly linked to compartmentalized meningeal inflammation. The topographical distribution of subpial demyelination can be appraised in vivo using surface-based mapping of magnetization transfer saturation (MTsat) in the cortex with 7T MRI. We combined 7T cortical MTsat mapping with [
methodsThirty-eight MS patients (median EDSS: 4.0) and 21 healthy controls (HCs) underwent high resolution 7T MRI and [
resultsMSHigh patients presented substantially greater, diffuse reductions in MTsat at all three cortical depths relative to HCs (P < 0.05). Areas of significantly reduced MTsat were greatest at 25% depth in the frontal, parietal and cingulate cortices, occupying nearly 70% of total cortical area and providing evidence of extensive subpial demyelination. Importantly, MSHigh patients presented increased microstructural abnormalities in subcortical regions (P < 0.05), alongside higher Expanded Disability Status Score (EDSS) (P = 0.02), increased odds of progressive MS (odds ratio = 4.85:1 [1.20, 23.26], P = 0.03) and significant cortical atrophy (P = 0.009). DISCUSSION: We provide in vivo evidence of a relationship between subcortical microglial inflammation and subpial demyelination in MS that is associated with increased clinical disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.